1345 TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes.
https://immunology.sciencemag.org/content/5/47/eabc3582
1344 Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.
https://www.nature.com/articles/s41586-020-2180-5
1343 Structural basis of receptor recognition by SARS-CoV-2.
https://www.nature.com/articles/s41586-020-2179-y
1342 Statin therapy is associated with lower prevalence of gut microbiota dysbiosis.
https://www.nature.com/articles/s41586-020-2269-x
1341 Structural studies show that a SARS antibody binds a conserved epitope on the viral spike distinct from the receptor-binding site.
https://science.sciencemag.org/content/368/6491/630
1340 The Structure of the Membrane Protein of SARS-CoV-2 Resembles the Sugar Transporter semiSWEET.
https://www.preprints.org/manuscript/202004.0512/v2
1339 An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.
https://stm.sciencemag.org/content/12/541/eabb5883
1338 The authors report near-atomic resolution structures of the R-type bacteriocin from Pseudomonas aeruginosa in the pre-contraction and post-contraction states, and these structures provide insight into the mechanism of action of molecular syringes.
https://www.nature.com/articles/s41586-020-2186-z
1337 The Structure of the Membrane Protein of SARS-CoV-2 Resembles the Sugar Transporter semiSWEET.
https://www.preprints.org/manuscript/202004.0512/v1
1336 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
https://www.cell.com/cell/fulltext/S0092-8674(20)30229-4
|
